参考文献/References:
[1] BOS P J,DEUTMAN A F.Acute macular neuroretinopathy[J].Am J Ophthalmol,1975,80(4):573-584.
[2] TURBEVILLE S D,COWAN L D,GASS J D.Acute macular neuroretinopathy:areview of the literature[J].Surv Ophthalmol,2003,48(1):1-11.
[3] 李妙玲,张雄泽,吉宇莹,叶佰康,文峰.急性黄斑神经视网膜病变的临床特征[J].中华眼底病杂志,2016,32(2):169-171.
LI M L,ZHANG X Z,JI Y Y,YE B K,WEN F.Clinical features of acute macular neuroretinopathy[J].Chin J Ocul Fundus Dis,2016,32(2):169-171.
[4] ZAMANI G,AZIMI S A,AMINIZADEH A,ABADI E S,KAMANDI M,MORTAZI H,et al.Acute macular neuroretinopathy in a patient with acute myeloid leukemia anddeceased by COVID-19:a case report[J].J Ophthalmic Inflamm Infect,2021,10(1):39.
[5] FAWZI A A,PAPPURU R R,SARRAF D,LE P P,MCCANNEL C A,SOBIN L,et al.Acute macular neuroretinopathy:long-term insights revealed by multimodal imaging[J].Retina,2012,32(8):1500-1513.
[6] BHAVSAR K V,LIN S,RAHIMY E,JOSEPH A,FREUND K B,SARRAF D,et al.Acute macular neuroret-inopathy:a comprehensive review of the literature[J].Surv Ophthalmol,2016,61(5):538-565.
[7] ASHFAQ I,VRAHIMI M,WAUGH S,SOOMRO T,GRINTON M E,BROWNINGA C.Acute macular neuroretinopathy associated with acute influenza virus infection[J].Ocul Immunol Inflamm,2021,29(2):333-339.
[8] WU P,DUAN F,LUO C,LIU Q,QU X G,LIANG L,et al.Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province,China[J].JAMA Ophthalmol,2020,138(5):575-578.
[9] GASCON P,BRIANTAIS A,BERTRAND E,RAMTOHUL P,DENIS D.Covid-19-associated retinopathy:a case report article history[J].Ocul Immunol Inflamm,2020,28(8):1293-1297.
[10] AIDAR M N,GOMES T M,ALMEIDA M Z H D,ANDRADE E P D,SERRACARBASSA P D.Low visual acuity due to acute macular neuroretinopathy associated with COVID-19:a case report[J].Am J Case Rep,2021,22:e931169.
[11] VIRGO J,MOHAMED M.Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection[J].Eye,2020,34(12):2352-2353.
[12] AZAR G,BONNIN S,VASSEUR V,FAURE C,SALVIAT F,CLERMONT C V,et al.Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy?[J].J Clin Med,2021,10(21):5038.
[13] JALINK M B,BRONKHORST I H G.A sudden rise of patients with acute macular neuroretinopathy during the COVID-19 pandemic[J].Case Rep Ophthalmol,2022,13(1):96-103.
[14] MASJEDI M,POURAZIZI M,HOSSEINI N S.Acute macular neuroretinopathy as a manifestation of coronavirus disease 2019:a case report[J].Clin Case Rep,2021,9(10):e04976.
[15] PRETI R C,ZACHARIAS L C,CUNHA L P,MONTEIRO M L R.Acute macular neuroretinaopathy as the presenting manifestation of COVID-19 infection[J].Retin Cases Brief Rep,2022,16(1):12-15.
[16] DAVID J A,FIVGAS G D.Acute macular neuroretinopathy associated with COVID-19 infection[J].Am J OphthalmolCase Rep,2021,24:101232.
[17] D’SOUZA H S,TAILOR P D,OLSEN T W.Seeing blue dots after COVID-19 infection[J].JAMA Ophthalmol,2023,141(1):97-98.
[18] STRAIN W D,CHATURVEDI N.The renin-angiotensin-aldos-terone system and the eye in diabetes[J].J Renin Angiotensin Aldosterone Syst,2002,3(4):243-246.
[19] REINHOLD A,TZANKOV A,MATTER M,MIHIC-PROBST D,SCHOLL H P N,MEYER P.Ocularpathology and occasionally detectable intraocular severe acute respiratory syndrome coronavirus-2 RNA in five fatal coronavirus disease-19 cases[J].Ophthalmic Res,2021,64(5):785-792.
[20] ZHANG Y,XIAO M,ZHANG S,XIA P,CAO W,JIANG W,et al.Coagulopathy and antiphospholipid antibodies in patients with COVID-19[J].N Engl J Med,2020,382(17):e38.
[21] HANFF T C,MOHAREB A M,GIRI J,COHEN J B,CHIRINOS J A.Thrombosis in COVID-19[J].Am J Hematol,2020,95(12):1578-1589.
[22] CENNAMO G,REIBALDI M,MONTORIO D,D’ANDREA L,FALLICO M,TRIASSI M.Optical coherence tomography angiography features in post-COVID-19 pneumonia patients:apilot study[J].Am J Ophthalmol,2021,227:182-190.